This chemical is primarily used in the development of pharmaceutical compounds, particularly in the synthesis of active ingredients for central nervous system (CNS) drugs. Its structure suggests potential applications in targeting neurological disorders, such as depression or anxiety, due to its ability to interact with neurotransmitter systems. Additionally, it may be explored for its role in creating novel antidepressants or anxiolytics, given its phenoxy and trifluoromethyl groups, which are often associated with bioactivity in CNS-targeting molecules. Research is ongoing to evaluate its efficacy and safety in therapeutic applications.